GLP2TZ

GLP2TZ — Dual Receptor Agonist Peptide Research Use Only | ≥98% Purity

GLP2TZ is a synthetic research peptide designed to interact with two distinct metabolic receptor pathways: the glucagon-like peptide-1 receptor (GLP-1R) and the glucose-dependent insulinotropic polypeptide receptor (GIPR). This dual-receptor targeting profile makes GLP2TZ of significant interest to researchers investigating incretin-based metabolic signaling, pancreatic beta-cell function, energy homeostasis, and receptor pharmacology in controlled laboratory settings.

GLP2TZ belongs to a class of synthetic peptides structurally based on the native GIP hormone sequence with GLP-1 receptor co-agonism activity, making it a valuable tool for comparative receptor binding studies and dual incretin pathway research.

All USA Made Peps GLP2TZ is independently third-party tested to a minimum purity of ≥98% by HPLC and mass spectrometry and supplied with a full Certificate of Analysis.

Available sizes:

• GLP2TZ — 10mg per vial (10 vial pack)
• GLP2TZ — 15mg per vial (10 vial pack)
• GLP2TZ — 30mg per vial (10 vial pack)

Supplied as lyophilized powder. Store at -20°C. For research use only.

For Research Use Only. Not for human or animal use. Not FDA-approved. Not intended to diagnose, treat, cure, or prevent any disease or condition. For in vitro laboratory research purposes only. Buyer assumes full responsibility for lawful use in their jurisdiction.